This content is machine translated Venous thromboembolism prevention PCSK9 inhibitors: Current evidence, mechanisms and unanswered questions Venous thromboembolism (VTE), consisting of deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cause of cardiovascular mortality worldwide after myocardial infarction and stroke. Despite continuous...…
View Post 4 min This content is machine translated Hemostaseology New concepts for a lifelong challenge – tumor-associated VTE. There has been a groundbreaking increase in knowledge in hemostaseology in recent years, both preclinically in basic research and clinically with the development of innovative treatment strategies. Using the patient…
View Post 5 min This content is machine translated Venous thromboembolism Clinical assessment and anticoagulant therapy – an update. If thromboembolism is not detected and treated in time, life-threatening consequences may result. Validated tests, such as the Wells score and the D-dimer test, can be used to assess the…
View Post 2 min This content is machine translated Anticoagulation Effective therapy of tumor-associated thromboembolism under discussion. What is the optimal therapy for tumor-associated venous thromboembolism? This question was addressed by two renowned scientists who weighed up the advantages and disadvantages of the available treatment options.
View Post 10 min This content is machine translated Preoperative anemia in the era of patient blood management (PBM). A pragmatic approach to diagnostics and therapy Preoperative anemia is an independent predictor of increased risk of infection, thromboembolism, and mortality. For their part, allogeneic blood transfusions further contribute to worsening outcomes through nonspecific and specific risks.…
View Post 3 min This content is machine translated Venous thromboembolism with suspected cancer Are increased screening efforts useful? Idiopathic venous thromboembolism may be early warning signs of tumor. According to older studies, up to 10% of those affected are diagnosed with cancer in the year following thrombosis [1].…
View Post 3 min This content is machine translated Venous thromboembolism Do patients with pancreatic cancer benefit from prophylaxis? Advanced pancreatic cancer is associated with a significantly increased risk of venous thromboembolism: within one year, approximately one fifth of patients suffer such a complication – with devastating consequences. What…
View Post 6 min This content is machine translated Venous thromboembolism Thrombophilic factors and the judicious use of laboratory diagnostics The currently known and established hereditary thrombophilias are statistically associated with an increased clinical risk of thrombosis. This risk is variably expressed and depends on the individual genetic background of…
View Post 2 min This content is machine translated Cancer and stroke Retrospective study offers little hope for stroke patients with cancer The aim of a new study was to find out how often and in what way recurrent thromboembolic events present after acute ischemic stroke. This only involved stroke patients who…
View Post 5 min This content is machine translated Obesity and contraception Contraindication for combined hormonal contraceptives? Women with obesity show an increased risk of poor contraception and unplanned pregnancies, as well as complications with hormonal contraceptives. Data regarding efficacy, effects on coagulation parameters and metabolism are…
View Post 3 min This content is machine translated Editorial Interventional percutaneous catheter ablation of VCF. When a patient presents for the first time with atrial fibrillation (AF) to the primary care physician’s office, an active search for possible secondary trigger factors, such as hyperthyroidism, should…
